[ تعرٌف على ] مستقبل منشط بمكاثر البيروكسيسوم النوع-غاما

تم النشر اليوم 08-12-2025 | [ تعرٌف على ] مستقبل منشط بمكاثر البيروكسيسوم النوع-غاما
تم النشر اليوم [dadate] | مستقبل منشط بمكاثر البيروكسيسوم النوع-غاما

التوزيع في الأنسجة

يتواجد PPARG أساسا في النسيج الدهني، القولون والبلعميات الكبيرة. عُثر على نظيرين من PPARG لدى البشر الفئران هما: PPAR-γ1 (يتواجد تقريبا في معظم الأنسجة باستثناء العضلات) وPPAR-γ2 (يتواجد في الغالب في النسيج الدهني والأمعاء).

قراءة إضافية

. Qi C، Zhu Y، Reddy JK (2001). "Peroxisome proliferator-activated receptors, coactivators, and downstream targets". Cell Biochem. Biophys. 32 Spring: 187–204. PMID:11330046. Kadowaki T، Hara K، Kubota N، Tobe K، Terauchi Y، Yamauchi T، Eto K، Kadowaki H، Noda M، Hagura R، Akanuma Y (2002). "The role of PPARgamma in high-fat diet-induced obesity and insulin resistance". J. Diabetes Complicat. ج.16 ع.1: 41–5. DOI:10.1016/S1056-8727(01)00206-9. PMID:11872365. Wakino S، Law RE، Hsueh WA (2002). "Vascular protective effects by activation of nuclear receptor PPARgamma". J. Diabetes Complicat. ج.16 ع.1: 46–9. DOI:10.1016/S1056-8727(01)00197-0. PMID:11872366. Takano H، Komuro I (2002). "Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease". J. Diabetes Complicat. ج.16 ع.1: 108–14. DOI:10.1016/S1056-8727(01)00203-3. PMID:11872377. Stumvoll M، Häring H (2002). "The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism". Diabetes. ج.51 ع.8: 2341–7. DOI:10.2337/diabetes.51.8.2341. PMID:12145143. Koeffler HP (2003). "Peroxisome proliferator-activated receptor gamma and cancers". Clin. Cancer Res. ج.9 ع.1: 1–9. PMID:12538445. Puigserver P، Spiegelman BM (2003). "Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator". Endocr. Rev. ج.24 ع.1: 78–90. DOI:10.1210/er.2002-0012. PMID:12588810. Takano H، Hasegawa H، Nagai T، Komuro I (2003). "The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy". Drugs Today. ج.39 ع.5: 347–57. DOI:10.1358/dot.2003.39.5.799458. PMID:12861348. Rangwala SM، Lazar MA (2004). "Peroxisome proliferator-activated receptor gamma in diabetes and metabolism". Trends Pharmacol. Sci. ج.25 ع.6: 331–6. DOI:10.1016/j.tips.2004.03.012. PMID:15165749. Cuzzocrea S (2005). "Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury". Vascul. Pharmacol. ج.41 ع.6: 187–95. DOI:10.1016/j.vph.2004.10.004. PMID:15653094. Savage DB (2007). "PPAR gamma as a metabolic regulator: insights from genomics and pharmacology". Expert Reviews in Molecular Medicine. ج.7 ع.1: 1–16. DOI:10.1017/S1462399405008793. PMID:15673477. Pégorier JP (2005). "[PPAR receptors and insulin sensitivity: new agonists in development]". Ann. Endocrinol. (Paris). ج.66 ع.2 Pt 2: 1S10–7. PMID:15959400. Tsai YS، Maeda N (2005). "PPARgamma: a critical determinant of body fat distribution in humans and mice". Trends Cardiovasc. Med. ج.15 ع.3: 81–5. DOI:10.1016/j.tcm.2005.04.002. PMID:16039966. Gurnell M (2006). "Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies". Best Pract. Res. Clin. Endocrinol. Metab. ج.19 ع.4: 501–23. DOI:10.1016/j.beem.2005.10.001. PMID:16311214. Cecil JE، Watt P، Palmer CN، Hetherington M (2006). "Energy balance and food intake: the role of PPARgamma gene polymorphisms". Physiol. Behav. ج.88 ع.3: 227–33. DOI:10.1016/j.physbeh.2006.05.028. PMID:16777151. Rousseaux C، Desreumaux P (2007). "[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)]". J. Soc. Biol. ج.200 ع.2: 121–31. DOI:10.1051/jbio:2006015. PMID:17151549. Eriksson JG (2007). "Gene polymorphisms, size at birth, and the development of hypertension and type 2 diabetes". J. Nutr. ج.137 ع.4: 1063–5. PMID:17374678. Tönjes A، Stumvoll M (2007). "The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk". Current opinion in clinical nutrition and metabolic care. ج.10 ع.4: 410–4. DOI:10.1097/MCO.0b013e3281e389d9. PMID:17563457. Burgermeister E، Seger R (2007). "MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma". Cell Cycle. ج.6 ع.13: 1539–48. DOI:10.4161/cc.6.13.4453. PMID:17611413. Papageorgiou E، Pitulis N، Msaouel P، Lembessis P، Koutsilieris M (2007). "The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines". Expert Opin. Ther. Targets. ج.11 ع.8: 1071–85. DOI:10.1517/14728222.11.8.1071. PMID:17665979.

شرح مبسط

1FM6, 1FM9, 1I7I, 1K74, 1KNU, 1NYX, 1PRG, 1RDT, 1WM0, 1ZEO, 1ZGY, 2ATH, 2F4B, 2FVJ, 2G0G, 2G0H, 2GTK, 2HFP, 2HWQ, 2HWR, 2I4J, 2I4P, 2I4Z, 2OM9, 2P4Y, 2POB, 2PRG, 2Q59, 2Q5P, 2Q5S, 2Q61, 2Q6R, 2Q6S, 2Q8S, 2QMV, 2VSR, 2VST, 2VV0, 2VV1, 2VV2, 2VV3, 2VV4, 2XKW, 2YFE, 2ZK0, 2ZK1, 2ZK2, 2ZK3, 2ZK4, 2ZK5, 2ZK6, 2ZNO, 2ZVT, 3ADS, 3ADT, 3ADU, 3ADV, 3ADW, 3ADX, 3AN3, 3AN4, 3B0Q, 3B0R, 3B1M, 3B3K, 3BC5, 3CDP, 3CDS, 3CS8, 3CWD, 3D6D, 3DZU, 3DZY, 3E00, 3ET0, 3ET3, 3FEJ, 3FUR, 3G9E, 3GBK, 3H0A, 3HO0, 3HOD, 3IA6, 3K8S, 3KMG, 3LMP, 3NOA, 3OSI, 3OSW, 3PBA, 3PO9, 3PRG, 3QT0, 3R5N, 3R8A, 3R8I, 3S9S, 3SZ1, 3T03, 3TY0, 3U9Q, 3V9T, 3V9V, 3V9Y, 3VJH, 3VJI, 3VN2, 3VSO, 3VSP, 3WJ4, 3WJ5, 3WMH, 3X1H, 3X1I, 4A4V, 4A4W, 4CI5, 4E4K, 4E4Q, 4EM9, 4EMA, 4F9M, 4FGY, 4HEE, 4JAZ, 4JL4, 4L96, 4L98, 4O8F, 4OJ4, 4PRG, 4PVU, 4PWL, 4R2U, 4R6S, 4XLD, 4R06, 4Y29, 4XTA, 4XUM, 4YT1, 4XUH, 5F9B, 5AZV